Shorts

GLP-1 Medication Beyond Weight-Loss Indications: Todd T. Brown, MD, PhD

Unmet NSCLC Needs Persist Despite Advances in Targeted Therapies: Estelamari Rodriguez, MD, MPH

Legal Accountability of AI and Software Companies vs Doctors: Brian Sheppard, JD, LLM

How Political Policy Is Impacting the Fight Against HIV: Peter Staley

Rising CRC in Younger Adults Underscores Urgent Need for Earlier Screening: Brooke McCormick

Oral vs Injectable GLP-1s: Eric Levin Talks Cost

Navigating Employer Coverage for GLP-1 Medications: Eric Levin

Local Funding Cannot Replace Federal Funding When Addressing HIV: Lindsey Dawson, MA

ADAPs Providing HIV Drugs Face Budget Crisis Across the Country: Lindsey Dawson, MA

Revised Childhood Vaccine Recommendations Could Affect Herd Immunity: Amy Crawford-Faucher, MD

Building Trust in Clinical Trials for Oncology: Amir Fathi, MD

Why Clinical Trials Are the Key to Beating Cancer: Amir Fathi, MD

How Academic Centers Can Support Community Hospitals: Andrew Yee, MD

Understanding the 3 Pillars of CRC Prevention: Jordan Karlitz, MD

Psoriasis Is More Than Just Skin Deep: James Song, MD

Is Your Genetic Risk a Piece of a Larger Puzzle? David Zhang, MD

Why New Cancer Treatments Widen the Inequity Gap: Sarah M. Lima, PhD, MPH

Future Legislation Will Need to Continue to Address Hidden Fees from PBMs, Make Fees More Transparent: Miriam Paramore

Whole-Genome Sequencing Clarifies Genetic Risk in IPF: David Zhang, MD

Why Zip Code Still Affects Cancer Survival: Sarah M. Lima, PhD, MPH

Why Independent Pharmacies Can't See Real Drug Costs: Miriam Paramore

Detecting Cancer Resistance Early via Liquid Biopsies: Ateequllah Hayat, PhD

How Breast Cancer Cells "Hide" From Treatment: Ateequllah Hayat, PhD

Why 100% Skin Clearance Is Not Always Enough: James Song, MD

PBM Reform Hinges on Making Prices Transparent for All: Miriam Paramore

Advanced Multiple Myeloma Therapies Require Dedicated Teams, 24/7 Support for Safe Patient Care: Ameet Patel, MD

Access, Geography, and Cost Limit Patient Participation in Clinical Trials: Susan Vadaparampil, PhD, MPH

How Successful Medically Integrated Dispensing Works in Practice: Kenneth Komorny, PharmD, BCPS

Weighing the Pros, Cons of Medically Integrated Dispensing: Katherine Tobon, PharmD, BCOP

Strengthening Trial Infrastructure to Broaden Patient Access: Tina Bhatnagar, DO